HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Do you think that the medical community has been too enthusiastic about testing for certain thrombophilic disorders? Alejandro Lazo-Langner, MD, MSc; Stephan Moll, MD
-
- Risk factors for VTE abound, but clinical utility is limited
- Abiraterone acetate associated with durable PSA responses
- Tapering clopidogrel before cessation did not lower platelet aggregation
- Thoughts from the ‘job’ trail William Wood, MD
- Friendship meets myelodysplasia head on Arthur Topilow, MD, FACP
- Expert recommends annual monitoring, injections of vitamin B12 for long-term metformin users
- High-dose radiation therapy showed superior long-term cancer control in prostate cancer
- Metastatic progression infrequent in low-risk prostate cancer treated with surgery or radiotherapy
-
- Substantial variation observed in treatment of localized prostate cancer
- Benefit of aggressive multiagent concurrent chemoradiotherapy for SCCHN similar despite patient age
- Metformin use lowered risk for cancer mortality
- RTOG 9911: Prognostic stratification possible in SCCHN patients
- Unilateral radiotherapy effective treatment for squamous cell carcinoma of the tonsil
- Comparing the HPV vaccines Debbie Blamble, PharmD, BCOP